InsuLearn Feasibility with Type 1 Diabetes Patients Under MDI Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.
Epistemonikos ID: 7521ec94f8c827674e3fe88d4bcbc04da719ad94
First added on: May 22, 2024